Vigoulet Auzil, France

Thierry Clerc

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 6.6

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • La Turbie, FR (2009)
  • Vigoulet Auzil, FR (2011 - 2013)

Company Filing History:


Years Active: 2009-2013

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Thierry Clerc

Introduction

Thierry Clerc is a notable inventor based in Vigoulet Auzil, France. He has made significant contributions to the field of pharmaceuticals, holding a total of five patents. His work focuses on the development of novel compounds with potential therapeutic applications.

Latest Patents

One of Thierry Clerc's latest patents is for 1-N-phenyl-amino-1H-imidazole derivatives and pharmaceutical compositions containing them. This invention relates to specific compounds that have been defined in the specification, which may offer new avenues for treatment. Another significant patent involves indazoles, benzisoxazoles, and benzisothiazoles, which are recognized for their use as estrogenic agents. The compounds described in this patent are modulators of estrogen receptors, highlighting their potential in medical applications.

Career Highlights

Throughout his career, Thierry Clerc has worked with reputable organizations, including Laboratoire Thermamex and Laboratoire Theramex. His experience in these companies has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.

Collaborations

Thierry Clerc has collaborated with notable colleagues such as Jean Lafay and Paule Bonnet. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Thierry Clerc's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work continues to influence the development of new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…